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Abstract 
Background: Whole cell biocatalysts and isolated enzymes are considered as state of the art in biocatalytic prepara‑
tions for industrial applications. Whole cells as biocatalysts are disadvantageous if substrate or products are toxic to 
the cells or undesired byproducts are formed due to the cellular metabolism. The use of isolated enzymes in com‑
parison is more expensive due to the required downstream processing. Immobilization of enzymes after purifica‑
tion increases preparation costs for biocatalysts significantly, but allows for the efficient reuse of the enzymes in the 
biocatalytic process. For a more rapid processing one‑step expression and immobilization is desirable.
Results: This study focused on the development of a new one‑step expression and immobilization technique for 
enzymes on the example of the β‑galactosidase from Escherichia coli K12. The enzyme was expressed in E. coli with 
a C‑terminal membrane anchor originating from cytochrome b5 from rabbit liver and was thus in situ immobilized 
to the inner surface of the cytosolic membrane. Then, the expression of a lytic phage protein (gene E from PhiX174) 
caused the formation of a pore in the cell wall of E. coli, which resulted in release of the cytosol. The cellular envelopes 
with immobilized enzymes were retained. Batch and fed‑batch processes were developed for efficient production 
of these biocatalysts. It was possible to obtain cellular envelopes with up to 27,200 ± 10,460 immobilized enzyme 
molecules per cellular envelope (753 ± 190 U/gdry weight). A thorough characterization of the effects of membrane 
immobilization was performed. Comparison to whole cells showed that mass transfer limitation was reduced in cel‑
lular envelopes due to the pore formation.
Conclusion: In this study the feasibility of a new one‑step expression and immobilization technique for the gen‑
eration of biocatalytic preparations was demonstrated. The technique could be a useful tool especially for enzyme 
systems, which are not suitable for whole‑cell biocatalysts due to severe mass transfer limitations or undesired side 
reactions mediated by cytosolic enzymes.
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Background
The application of whole cells and isolated enzymes are 
state-of-the-art techniques for industrial processes. 
Whole cell biocatalysts are cheap in production and 
have internal cofactor regeneration [1]. However, they 
can produce undesired byproducts due to the cellular 
metabolism, which complicate downstream processing 
[2]. Moreover, the cell wall can cause mass transfer limi-
tation and toxic substrates or byproducts can be greatly 
damaging to the whole cell biocatalyst [1–4]. Therefore, 
enzymes are frequently purified. This does, of course, pre-
vent the formation of undesired byproducts and thereby 
greatly facilitates the downstream processing [5]. How-
ever, the purification of enzymes is expensive in time and 
costs, causes losses during the purification and possibly a 
reduction in the catalytic activity [6, 7]. Immobilization 
of enzymes after purification increases preparation costs 
for biocatalysts, but allows for the efficient reuse of the 
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enzymes in the biocatalytic process [5, 8]. The majority 
of immobilization techniques either use artificial surfaces 
to attach or encapsulate the catalyst in artificial particles 
[8]. Furthermore, purification is required prior to the 
immobilization, which is time consuming and cost inten-
sive. An immobilization technique, which offers one-step 
expression and immobilization is therefore desirable. The 
“outer surface- or auto-display” of enzymes on the outer 
membrane of the cells is one studied option [4, 9, 10]. 
Here, the enzymes are attached to the outer membrane 
by fusing them to outer membrane proteins or so called 
autotransporters, to ensure sufficient translocation of the 
enzymes to the outer membrane [9–11]. Moreover, such 
whole cell biocatalysts displaying enzymes on their sur-
face retain their complete metabolism, which can again 
cause the formation of undesired byproducts. Therefore, 
a new approach of one-step expression and immobiliza-
tion was aimed for.
A new option studied in this work is immobilization of 
the desired enzyme or enzyme system to the inner mem-
brane of Escherichia  coli (E.  coli). Biocatalysts are then 
created as cellular envelopes which contain afore immo-
bilized enzymes by the removal of the cytosol. The cyto-
sol can be removed by the formation of a pore by the lytic 
protein E from phage PhiX174. Protein E is a 91 amino 
acid long protein which lacks catalytic activity [12]. It 
inserts into the inner membrane of gram-negative cells. 
Subsequently, a conformational change takes place which 
eventually leads to fusion of inner and outer membrane 
due to protein E. A lysis pore (40–200 nm) is formed, the 
cytosol is released due to the osmotic pressure and a cel-
lular envelope is retained. The cellular envelopes allow 
harvesting and treatment similar to whole cells [13–15]. 
If proteins with membrane anchors were expressed prior 
to lysis, the cellular envelope will contain afore immobi-
lized enzymes [16]. Generally, the lytic phage protein E 
can be used to create cellular envelopes from gram nega-
tive bacteria and has a wide variety of applications [14, 
17]. So far most studies focused on the generation of 
vaccines from pathogens. First experiments on immo-
bilization within the cellular envelopes regarded addi-
tional antigens to enhance immune response, which were 
expressed in low amounts [16].
This paper is focused on the efficient preparation 
of E. coli cell envelopes with large amounts of immo-
bilized enzymes at the inner surface of the cytosolic 
membrane. A schematic description is given in Fig.  1. 
β-Galactosidase from E.  coli  K12 was chosen to be 
immobilized as a model enzyme using the C-terminal 
hydrophobic sequence from cytochrome  b5 from rab-
bit liver. This fusion protein has been described to insert 
spontaneously into membranes and liposomes [18]. 
C-terminal membrane anchoring is assumed to occur 
posttranslationally [18, 19]. So the new technique was 
independent from signaling peptides and trans-mem-
brane channeling.
Results and discussion
Production of cellular envelopes with immobilized 
β‑galactosidase
In order to evaluate the new system, the β-galactosidase 
from E.  coli K12 was fused with the C-terminal hydro-
phobic sequence of cytochrome  b5 from rabbit liver, 
resulting in the β-gal-cyt  b5-fusion protein [18]. So far, 
research regarding phage PhiX174 protein E mediated 
lysis focused on generating various vaccines, which do 
not require high expression levels of the antigen [16]. 
In this work biocatalyst were aimed for, which conse-
quently need high numbers of enzyme molecules to pro-
vide sufficient catalytic activity. High expression levels of 
membrane proteins are often damaging to the cells [20, 
21]. As the cellular vitality is crucial for protein E medi-
ated lysis [12, 22], a low to medium copy number plas-
mid (pCOLADuet®) and a high copy number plasmid 
(pET28a) were compared. Cultivation in a stirred tank 
reactor was used to validate industrial applicability and to 
ensure cellular vitality by supply with sufficient amounts 
of dissolved oxygen and nutrients. Batch and fed-batch 
processes were compared to find the best expression con-
ditions. In all experiments E.  coli  C41  (DE3) cells were 
used as they are better able to maintain cellular vitality 
despite membrane protein overexpression [20]. Cells 
were grown and subsequently chemically induced with 
isopropyl β-d-1-thiogalactopyranoside (IPTG). Lysis by 
protein E expression was controlled using the tempera-
ture sensitive promotor cI857 and lysis was induced by 
a shift to 42  °C. Cellular envelopes were washed using 
tangential flow filtration and analyzed for biocatalytic 
activity. A schematic description of the process is given 
in Fig. 2.
It was possible to obtain successful overexpression and 
lysis in all experimental setups with IPTG concentra-
tions ≤0.1  mM, regardless if batch or fed-batch mode 
was used. Higher IPTG concentrations rendered the 
cells unfit for E mediated lysis. All processes with respec-
tive conditions offered lysis yields of >99.0  %. Notably, 
all obtained cellular envelopes exhibited catalytic activ-
ity. So, it was possible to generate new biocatalysts con-
sisting of the cellular envelope with membrane bound 
β-gal-cyt b5. Cultivation in a stirred tank reactor was suc-
cessfully used for the production, indicating feasibility for 
industrial applications. The main process parameters and 
results are summarized in Table 1. Additionally, permit-
tivity measurements with a biomass probe were used for 
the observation of E mediated lysis. The polarizability and 
thus the permittivity of a cell culture can be correlated to 
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biomass concentration, the higher the polarizability, the 
more cells and the higher the biomass concentration [23]. 
It was possible to detect E mediated lysis as the decline 
in permittivity caused by the loss in membrane potential 
of the cells. Figure  3 shows exemplary data from a fed-
batch process. As depicted, the permittivity increases 
with cellular proliferation. During lysis a sudden decrease 
can be observed caused by the disruption of the cell 
and loss of the cytosol. The data also coincide with the 
amount of dissolved oxygen which increases as lysed 
cells no longer require oxygen. The increase in dissolved 
oxygen along with a decrease of the optical density is an 
indicator for E mediated lysis [14]. Notably, the amount 
of dissolved oxygen also increases if cells die due to low 
cellular vitality, while permittivity is largely maintained in 
that case (data not shown). So, the observation of permit-
tivity offers a new tool for the observation of E mediated 
lysis on production scale. The cellular envelopes gained 
under different conditions (batch and fed-batch process) 
containing the immobilized β-gal-cyt  b5 were washed 
using tangential flow filtration and analyzed for enzyme 
activity. Lyophilized cellular envelopes were stained with 
RH414 and the corresponding positive population was 
detected using flow cytometry. The dye RH414 binds to 
membranes and can be used to stain cells and cellular 
envelopes to remove background noise caused by other 
particles for a more accurate quantification [24]. The data 
was used to obtain a dry weight to particle concentration 
correlation (see Additional file 1: Figure S1). According to 
the correlation, the amount of activity per dry weight of 
Fig. 1 Schematic display of the new technique using E mediated lysis. 1 Expression of β‑galactosidase as a model enzyme with C‑terminal 
membrane anchor from cytochrome b5 (rabbit liver), posttranslational tetramer formation and inner membrane insertion. 2 Expression of lytic 
phage protein E and insertion into the cell membranes. 3 Pore formation by protein E and lysis with release of the cytosol. 4 Cellular envelope with 
immobilized enzymes and lysis pore
Fig. 2 Schematic display of the production process. Expression in batch and fed‑batch processes was chemically induced using 0.1 mM IPTG. 
Biomass formation was performed as a batch process in all experiments
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cellular envelopes was calculated. The results for all dif-
ferent experimental setups are compared in Table 1. Both 
batch processes yielded more than twofold higher activi-
ties per dry weight than those obtained in fed-batch cul-
tivation with up to 753 ± 190 U/gdry weight. Compared to 
the fed-batch process the activity per dry weight in both 
batch processes was higher, however the final cell dry 
weight (CDW) concentration was bisected. So the total 
activity obtained in all processes was roughly the same. 
As these were first approaches, the increase of final CDW 
concentrations prior to lysis should be a target of future 
experiments. As the maximum amount of enzymes per 
cellular envelope was of interest, all further experiments 
employed cellular envelopes that were produced in batch 
mode with the pET28a vector. The new biocatalysts were 
characterized regarding the amount of immobilized 
enzyme molecules per cellular envelope, the effect of the 
immobilization on the enzyme activity and alterations in 
mass transfer limitation.
Characterization of the new biocatalyst
First, the number of immobilized enzyme molecules 
was determined. Therefore, a sandwich enzyme linked 
immunosorbent assay (ELISA) was established. Purified 
β-galactosidase was used to calculate the correspond-
ing amount of β-gal-cyt b5 molecules within one cellular 
envelope. The cellular envelopes were disrupted using 
sonication and detergent prior to the application to the 
assay in order to solubilize the immobilized enzymes. 
However, the applied method did not enable a complete 
solubilization of all membrane bound enzymes. There-
fore, the result was corrected according to the residual 
activity detected in the debris after disruption. Notably, 
the application of the detergent did not have an effect on 
enzyme activity (see Additional file 2: Figure S2). Multiple 
batch processes with pET28a vector were analyzed. Using 
sandwich ELISA quantification the amount of membrane 
bound β-gal-cyt  b5 molecules in this first attempt was 
determined already to be 27,200 ± 10,460 per E. coli cell 
envelope. The highest amount of immobilized enzyme 
molecules on the outer membrane was achieved using 
a P450 enzyme with up to 180,000 molecules per E. coli 
cell [11, 25]. Generally, the number of immobilized mol-
ecules using surface display ranges between 15,000 and 
180,0000 [25]. So, the number of molecules displayed on 
bacterial surfaces is depending on the kind of enzyme 
used and the new system can assumed to be generally 
in the same order of magnitude as the outer membrane 
system. Therefore, the establishment of the new one-step 
immobilization and expression technique for new biocat-
alysts was successful.
For a thorough characterization of the new technique, 
the effect of membrane immobilization was determined. 
The solubilization of β-gal-cyt b5 from cellular envelopes 
was incomplete and for a characterization of the β-gal-
cyt  b5 a complete solubilization was required. β-gal-
cyt b5 is known to insert spontaneously to artificial and 
cellular membranes [18, 19]. Therefore, β-gal-cyt b5 was 
immobilized to artificial liposomes which could be eas-
ily degraded by detergents. Liposomes were generated 
as small unilamellar vesicles (SUV). The cleared lysate 
from cells overexpressing β-gal-cyt b5 was applied to the 
liposomes. It contained soluble β-gal-cyt  b5 molecules 
that were not inserted into the plasma membrane. It was 
possible to immobilize β-gal-cyt b5 to artificial SUV from 
crude protein extracts. Notably, as only crude extract was 
used, other E. coli host cell proteins also immobilized to 
the artificial liposomes (see Additional file 3: Figure S3). 
Table 1 Summary of process parameters and results
Expression was chemically induced with 0.1 mM IPTG after biomass formation in a batch phase at 35 °C
CDW cell dry weight




CDW concentration  
prior to lysis, g/L
Activity per dry weight 
cellular envelopes, U/g
Fed‑batch pCOLADuet 18 25 8.5 ± 0.3 312 ± 29
Batch pCOLADuet 3 35 4.3 ± 0.3 632 ± 250








































Expression (fed-batch) Lysis (fed batch)
Fig. 3 Exemplary online data from a fed‑batch process. The dissolved 
oxygen (black), the temperature (dark gray) and the permittivity (light 
gray) are displayed as function of process time. The three phases of 
the experiment, biomass formation, expression and lysis are indicated
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The obtained liposomes contained sufficient activity for 
a characterization of the immobilized β-gal-cyt  b5. The 
artificial SUV were analyzed in activity assays and sub-
sequently disrupted by detergent. Sandwich ELISA was 
used to quantify the number of enzyme molecules bound 
to the liposomes. Using the activity prior to disruption 
and the amount of β-gal-cyt  b5 detected using ELISA, 
the activity of the membrane bound molecules was cal-
culated. The calculated activity of membrane bound and 
soluble β-gal-cyt b5 were compared to a reference activ-
ity gained from purified β-galactosidase with N-termi-
nal His6–tag using the same conditions. The results are 
summarized in Fig.  4. The activity of membrane bound 
β-gal-cyt b5 was 324 ± 9 U/mg, whereas the free β-gal-
cyt b5 had an activity of 239 ±  4 U/mg. So, the activity 
was increased by 35.5 ± 7.8 % due to the immobilization 
on the membrane. Notably, the reference activity deter-
mined using purified β-galactosidase with N-terminal 
His6-tag was 206  ±  20  U/mg and consequently lower 
than the activity of soluble β-gal-cyt  b5. However, tak-
ing the standard deviation into account it was only mar-
ginally smaller. Generally, the activity was enhanced by 
immobilization rather than decreased. Immobilization of 
enzymes can have multiple effects which result in altered 
enzyme properties [26, 27]. As the β-galactosidase is a 
tetramer, one possible explanation could be the stabili-
zation of the tetramer in membrane bound multimers. 
If multimeric proteins are not connected colvalently, 
e.g. by disulfide bonds, they can be prone to dissocia-
tion. The rate constants of association and dissociation 
then reduce the catalytic activity of the multimer [26]. 
It has been demonstrated, that attachment of multim-
ers to surfaces can prevent dissociation of the subunits. 
Consequently the multimer is stabilized and enzyme per-
formance enhanced compared to the unbound enzymes 
[26, 27]. A respective stabilization can be assumed a 
possible explanation for the increased activities of mem-
brane bound β-gal-cyt b5 compared to the free enzyme. 
Moreover, the data concurs with data from George et al., 
who also describe an increased activity of the membrane 
bound fusion compared to the soluble enzyme [18].
Analysis of mass transfer limitation
One issue frequently faced when using immobilized 
enzymes and whole cell biocatalysts is mass transfer limi-
tation of substrates or co-factors [1–4]. Therefore, mass 
transfer was analyzed in cellular envelopes with mem-
brane bound β-gal-cyt b5 compared to whole cells. Activ-
ity assays were used to compare cellular envelopes and 
whole cells sampled after expression but prior to lysis. 
Additionally, whole cells taken prior to lysis were treated 
with detergent in order to overcome mass transfer limita-
tion. Exemplary data is given in Fig. 5. As demonstrated, 
cells prior to lysis had a reduced activity compared to 
cellular envelopes. So, due to the formation of the pore 
mass transfer limitation was reduced. The activity of cells 
treated with detergent was assumed as 100  %. As the 
detergent treatment had no effect on enzyme activity (see 
Additional file 3: Figure S3) it equaled the maximum pos-
sible activity with no mass transfer limitation due to the 
cell wall. Cellular envelopes contained 78 ±  13 % activ-
ity and cells prior to lysis 26 ± 10 %, respectively. Nota-
bly, not all activity is retained in cellular envelopes after 
lysis. As described above, C-terminal membrane immo-
bilization is assumed to occur posttranslationally and is 
also incomplete [18, 19]. So, the difference in activity of 
cellular envelopes can be explained by the loss of solu-
















Fig. 4 Comparison of activities of free and membrane bound β‑gal‑
cyt b5. The activity of β‑gal‑cyt b5 immobilized to SUV (a) and the 
activity of the same samples after solubilization of β‑gal‑cyt b5 by 
detergent treatment (b) are compared. The reference activity (c) was 



























Fig. 5 Comparison of β‑gal‑cyt b5 activity in whole cells and cellular 
envelopes for the analysis of mass transfer limitation. The β‑gal‑cyt b5 
activity was compared in whole cells prior to expression, whole cells 
prior to lysis, whole cells treated with detergent and cellular enve‑
lopes after workup. All samples were adjusted to equivalent particle 
concentrations using RH414 staining in flow cytometry
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amount of membrane bound activity concurs with data 
described by George et  al., who reported up to 80  % of 
immobilized enzyme activity of a similar β-gal-cyt  b5 
enzyme [18]. It was possible to demonstrate a reduc-
tion in mass transfer limitation due to the formation of 
the lysis pore. The new biocatalysts thus proved better 
catalysts than whole cells prior to lysis regarding this 
application.
Conclusion
A new one-step expression and immobilization system 
was established for the production of cellular envelopes 
with immobilized enzymes as new biocatalytic prepa-
rations. Batch and fed-batch cultivation of E. coli in a 
stirred tank reactor were used to produce cellular enve-
lopes by protein E mediated lysis, which contain afore 
immobilized fusion protein β-gal-cyt  b5 attached to the 
inner surface of the cytosolic membrane. Permittiv-
ity measurements were used for the detection of pro-
tein E mediated lysis. It was possible to obtain cellular 
envelopes which contain 27,200  ±  10,460 β-gal-cyt  b5 
molecules with an activity of 753 ±  190  U/gdry  weight. A 
thorough characterization of the effects of membrane 
immobilization was possible. By immobilizing the β-gal-
cyt  b5 to artificial liposomes, the effect of membrane 
immobilization was characterized. Notably, the activ-
ity was increased by 35.5  ±  7.8  % after immobilization 
to the membrane compared to the soluble β-gal-cyt  b5. 
This observation can be explained by the stabilization of 
the β-gal-cyt b5-tetramer in the membrane. Additionally, 
mass transfer limitation was analyzed. It was demon-
strated that mass transfer limitation is reduced due to the 
pore in the cell envelope formed due to protein E medi-
ated lysis. So, the cellular envelopes proved advantageous 
compared to whole cells prior to lysis. A new tool for the 
production of immobilized enzymes as biocatalytic prep-
arations was established. The new technique offers an 
alternative for whole-cell biotransformations which are 
limited by mass transfer limitation or rendered inapplica-




All chemicals were purchased from various suppli-
ers in analytical grade and were used without further 
purification.
Cloning
All primers were purchased at Eurofins MWG Operon 
(Ebersberg, Germany) unless stated otherwise. The 
β-galactosidase with cytochrome  b5 membrane anchor 
was cloned in allusion to George et  al. [18]. The 
β-galactosidase was amplified from genomic DNA from 
E. coli K12 using primers eliminating the stop codon and 
cloned into the pCOLADuet® (Novagen®, Merck KGaA, 
Darmstadt, Germany) vector via NcoI and AscI. The oli-
gonucleotides for the cytochrome  b5 membrane anchor 
were purchased from biomers.net (Ulm, Germany) as 
5′-phsophorylated single strands containing a stop codon 
(see Additional file 4: Table S1). The single strands were 
prepared by heating the solution to 95 °C for 5 min. After 
alignment for 30  min at 65  °C, they were cloned to the 
C-terminus of the β-galactosidase via AscI and NotI. For 
cloning of the fusion protein β-gal-cyt b5 to the pET28a 
vector (Novagen®, Merck KGaA,Darmstadt, Germany), 
the DNA was amplified and inserted into the vector via 
NheI and XhoI. For expression and purification of the 
β-galactosidase without membrane anchor, the corre-
sponding gene was amplified with N-terminal His6-tag 
from genomic DNA and cloned to pET28a via NcoI and 
XhoI.
Standard methods were used for PCR, ligation, trans-
formation and plasmid preparation as described in Sam-
brook and Russel [28].
The pGlysivb vector containing the lysis gene E from 
PhiX174 controlled by the temperature sensitive promo-
tor cI857 is described in Jechlinger et al. [29].
Microorganisms
Cloning was conducted using E.  coli DH5α cells (Invit-
rogen, Carlsbad, USA). All expressions were performed 
with E. coli C41 (DE3) cells (Lucigen® Corporation, Mid-
dleton WI, USA) containing pGlysivb and pCOLADuet® 
or pET28a with β-gal-cyt b5.
Media
For long term storage and determination of colony form-
ing units the cells were kept on Plate Count Agar (Carl 
Roth, Karlsruhe, Germany). A defined medium accord-
ing to Delisa et  al. [30] was used for cultivation in the 
stirred-tank reactor and the corresponding precultures 
in shaking flasks. In all other cases LB medium was used. 
In batch processes the initial glucose concentration was 
20 g/L. In fed-batch processes the initial glucose concen-
tration was 5 g/L during biomass formation. During feed-
ing the growth rate was adjusted using a modified feeding 
medium containing 50–100 g/L glucose, 5 g/L antifoam 
204 (Sigma-Aldrich, München, Germany), 2.5  g/L 
MgSO4,  5  mg/L Fe(III)  citrate, 1.63  mg/L ethylenedi-
aminetetraacetic acid (EDTA), 2  mg/L  Zn(CH3COO)2, 
2.5  mg/L CoCl2, 15  mg/L MnCl2, 3  mg/L H3BO3 and 
2.5 mg/L Na2MoO4. 10 µg/mL gentamycin and/or 30 µg/
mL kanamycin were added as required for selection.
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Cultivation in a stirred tank reactor
For precultures a single colony was used to inocu-
late 4  mL LB. 1  mL  cells were subcultured and used to 
inoculate an unbaffled shaking flask containing defined 
medium at 20  % nominal volume. After incubation at 
30  °C, 200  rpm overnight, the cells were harvested, 
concentrated to 1/5 of the initial volume and used for 
inoculation.
Batch and fed-batch cultivations were performed in 
a 3.6  L stirred-tank reactor (Infors-HT, Bottmingen, 
Switzerland), which was equipped with two Rushton 
turbine impellers. Cells from precultures were used to 
inoculate 1.5  L medium to an initial optical density at 
600 nm (OD600) of 0.5. The pH was adjusted to 7.2 using 
12.5 % (v/v) NH4OH and 1 M H3PO4. The dissolved oxy-
gen was set to >20 % pO2 air saturation by adjusting the 
aeration up to 8 L/min, the stirrer was set to 1000 rpm. 
The permittivity was observed using a biomass probe (I 
biomass, HAMILTON Bonaduz AG, Bonaduz, Swiz-
erland). In batch processes the temperature was 35  °C 
during biomass formation and expression. In fed-batch 
processes the temperature was 35 °C during biomass for-
mation and 25  °C during expression. In batch and fed-
batch processes expression was induced using 0.1  mm 
IPTG. For batch processes the cells were induced at 
OD600 ~ 1.5 to ensure sufficient amounts of glucose dur-
ing lysis. The expression lasted 3 h at 35 °C. In fed-batch 
cultivations, the expression was induced upon glucose 
depletion and lasted 18 h at 25 °C. Feeding was initiated 
in fed-batch cultivations upon glucose depletion. An 
exponential growth was adjusted during expression with 
µs  =  0.075  1/h according to Jenzsch et  al. [31]. During 
lysis in fed-batch processes the growth rate was increased 
to µs = 0.3 1/h until glucose accumulation was detected. 
At this point the feeding was stopped. The process was 
terminated in both batch and fed-batch mode by initiat-
ing E mediated lysis using a temperature shift to 42 °C, as 
described by Langemann et al. [14]. When the decline in 
OD600 and increase in dissolved oxygen (pO2) indicated 
lysis, 50 µg/mL ampicillin were added.
Workup of cellular envelopes
Concentration and washing was achieved by tangential 
flow filtration according to Langemann et  al. [14] using 
a 0.22 µm hollow fiber module with 4.2 m2 surface. After 
lysis the cellular envelopes were concentrated to 1/3 of 
the initial volume. Then, the cellular envelopes were fro-
zen at −20 °C and subsequently washed three times using 
phosphate buffered saline (PBS), pH 7.4 with 1:3 dilu-
tion in each step. The cellular envelopes were stored at 
−20 °C.
Colony forming units
Colony forming units (cfu) were used to quantify the lysis 
yield. Samples were diluted accordingly in sterile 0.85 % 
(w/v) NaCl and spread on agar plates containing no anti-
biotics. After breeding at 30 °C overnight, the lysis yield 
was determined by counting the cfu.
Protein expression
Expression and purification of β-galactosidase with 
C-terminal His6–tag and gal-cyt b5 for liposome forma-
tion was performed in unbaffled shaking flasks with LB 
medium at 20  % nominal volume, which were inocu-
lated from a single colony. Expression and purification 
of the β-galactosidase with C-terminal His6-Tag was 
performed as described in Sührer et al. [32]. For expres-
sion of β-gal-cytb5 for liposome experiments, the cells 
were grown until OD600 was 0.6 and induced with 1 mM 
IPTG. Expression lasted for 3 h at 35  °C. Subsequently, 
the cells were harvested and PBS containing 1 mM phe-
nylmethanesulfonylfluoride (PMSF) was added at a ratio 
of 5  mL per g wet pellet weight. Then, the cells were 
disrupted using a 2  mm tip sonicator for 10  min with 
an amplitude of 126.5 µm and the lysate was cleared for 
30  min at 50,000xg. Soluble membranes were removed 
from the clear supernatant by ultracentrifugation for 
1  h, 125,000×g at 4  °C. Subsequently, the soluble pro-
tein was concentrated to 1/5 of the initial volume using 
3 kDa molecular weight cut off (MWCO) Amicon Ultra-
15 spin columns (Merck Millipore, Darmstadt, Germany) 
at 4500×g.
ELISA
Prior to application, samples were treated with Popcul-
ture® detergent (Merck Millipore, Darmstadt, Germany) 
according to manufacturer’s instructions. Cellular enve-
lopes were additionally disrupted with a 2 mm tip sonica-
tor for 10 min with an amplitude of 126.5 µm for 10 min 
and subsequently harvested (30  min, 50,000×g). Then, 
the protein concentration was determined in samples 
from cellular envelopes using the Pierce® bicinchonic 
acid (BCA) protein assay kit (Thermo Scientific, Schw-
erte, Germany) according to manufacturer’s instructions 
and the samples were diluted to 20  µg/mL. Liposomes 
were treated with detergent only and applied without 
centrifugation using dilutions of 1:20–1:60. All sam-
ples were diluted in PBS, pH  7.4. A standard sandwich 
ELISA protocol was used according to http://www.
abcam.com/ (accessed in November 2014). Sandwich 
ELISA was performed using Maxisorp® Plates (Nunc®, 
Roskilde, Denmark). The capture antibody (monoclo-
nal anti β-galactosidase from mouse, MA1-152, Thermo 
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Scientific, Schwerte, Germany) was applied at a 1:2000 
dilution in coating buffer (0.1  M  sodium carbonate, 
pH 9.6) for 2 h at room temperature (RT). 5 % (w/v) milk 
powder in PBS (blocking buffer) was used for blocking 
for 2 h at RT. Then, 100 µL of the diluted samples were 
applied in duplicates and incubated for 1.5  h at 37  °C. 
The detection antibody (polyclonal anti β-galactosidase 
from rabbit, PA1-21477, Thermo Scientific, Schwerte, 
Germany) was applied at a 1:8000 dilution (in blocking 
buffer) over night at 4 °C. Then, the secondary antibody 
(Goat Anti Rabbit IgG H&L antibody HRP, Biorbyt Lim-
ited, Cambridge, United Kingdom) was applied (1:20,000 
dilution in blocking buffer) for 2 h at RT. Detection was 
achieved by application of 3,3′,5,5′-tetramethylbenzidine 
(TMB) Substrate Solution (Thermo Scientific, Schwerte, 
Germany) according to manufacturer’s instructions. The 
colorimetric change was detected at 450 nm and a stand-
ard with purified β-galactosidase was run along at con-
centrations of 0.05–1.0 µg/mL for quantification.
Flow cytometry
Flow cytometry was performed using the CyFlow® 
SL (Partec, Münster, Germany). Samples were 
stained with 0.75  µM  Bis-(1,3-Dibarbituric acid)-
trimethine oxanol  (DIBAC4 [3]) and 3  µM  N-(3-
Triethylammoniumpropyl)-4-(4-(4-(diethylamino)
phenyl)butadienyl)pyridinium dibromide  (RH414) prior 
to analysis. The determination of populations was per-
formed according to Langemann et al. [14] and Jechlinger 
et  al. [29]. The particle concentration from populations 
with positive RH414 staining was used to adjust particle 
concentrations of whole cells and cellular envelopes for 
activity assays and ELISA.
Liposome production
Thin layer rehydration was used to generate liposomes 
as SUV. 2  mg/mL  1-palmitoyl-2-oleoylphosphatidylcho-
line  (POPC) were diluted in ethanol (99.5 %) in a 5 mL 
round bottom flask and a thin layer was formed using a 
rotational evaporator. The lipid was further dried using a 
vacuum desiccator for 30 min. Then, 2 mL PBS (pH 7.4) 
were added and film rehydration was achieved by rota-
tion for 30 min at RT. The liposomes were cleared from 
not incorporated lipid by centrifugation for 6  min at 
13,000×g and sonicated using a 2  mm tip sonicator for 
3 min with an amplitude of 25.3 µm. Then, the concen-
trated soluble protein containing β-gal-cyt b5 was added 
at a ratio of 1:3 and 1:5 to the liposomes. The liposomes 
were incubated for 1 h at 30 °C at 250 rpm in a thermal 
shaker and subsequently washed twice by ultracentrifu-
gation at 125,000×g for 1  h, 4  °C. SDS-Page analysis of 
liposomes was performed according to Sambrook and 
Russell [27].
Activity assay
β-Galactosidase activity assays were detected using 
ortho-nitrophenyl-β-galactoside (oNPG). In 1  mL total 
volume 50 µL of diluted sample were analyzed in 0.1 M 
potassium phosphate buffer containing 0.124  M  2-mer-
captoethanol, 1 mM MgCl2, pH 7.0 with 1 mM oNPG at 
RT. The colorimetric change was detected at 436 nm and 
the slope was used to calculate the corresponding activ-
ity using the molar extinction coefficient εoNP  =  3.51/
(mM  cm). The activity in permeate from cellular enve-
lope workup using tangential flow filtration and in super-
natant from SUV production was measured in order to 
detect background activity from soluble β-gal-cyt b5. The 
results were corrected accordingly.
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